DoubleChecks

What was claimed

A peer-reviewed paper proves Ivermectin, Mebendazole and Fenbendazole protocol treats/cures cancer; this is the future of cancer treatment.

Our verdict

Inaccurate

The cited protocol relies mainly on preclinical evidence, case reports, and studies that did not test cancer effectiveness in humans. Peer review alone does not establish clinical efficacy. While drug-repurposing research is active, expert reviews and oncology societies state evidence is insufficient to call these agents the future standard of care; more rigorous randomized trials would be required.

Combined assessment18 sourcesChecked Oct 20, 2026

Why this verdict

  • A peer-reviewed paper proves Ivermectin, Mebendazole and Fenbendazole protocol treats/cures cancer.

    Incorrect
    All assessments reached this conclusion

  • The protocol cures cancer.

    Incorrect
    One assessment reached this conclusion

  • This protocol is the future of cancer treatment.

    Can’t verify
    One assessment reached this conclusion; one differed·ChatGPT: Misleading

Evidence reviewed

18 sources

Perplexity, Claude and ChatGPT sources are combined here.

science.feedback.orgonedaymd.comstateofthenation.infosmartcancer.orgyahoo.comnaturalnews.commedshadow.orgcancer.aestheticsadvisor.comrescue.substack.combrianlawenda.substack.com

Individual assessments

Assessment summary

  • The claim substantially overstates the evidence.
  • A peer-reviewed protocol does not prove that ivermectin, mebendazole, or fenbendazole treats or cures cancer, and no completed randomized trial establishes such a cure.science.feedback.org smartcancer.org

Claims reviewed

A peer-reviewed paper proves an ivermectin, mebendazole, and fenbendazole protocol treats cancer.

Incorrect
The cited protocol relies mainly on preclinical evidence, case reports, and studies that did not test cancer effectiveness in humans.science.feedback.org Peer review alone does not establish clinical efficacy.

This claim may mislead readers without added context.

The protocol cures cancer.

Incorrect
No completed randomized controlled trial has shown that these drugs cure cancer in humans.smartcancer.org Reported anecdotes and uncontrolled observations cannot establish a cure.

This claim may mislead readers without added context.

This protocol is the future of cancer treatment.

Can’t verify
This is a prediction, not a currently testable fact. The available evidence supports further research, not a conclusion that the protocol will become standard cancer treatment.smartcancer.org

Assessment summary

  • The claim significantly misrepresents the current state of evidence.
  • While peer-reviewed papers exist on these drugs, none "prove" they treat or cure cancer in humans.
  • Clinical evidence is absent or extremely limited, with only preclinical and anecdotal data available.
  • The claim's assertion that this represents "the future of cancer treatment" is speculative and contradicted by major oncology organizations.</reasoning> <parameter name="claims">[ { "claim": "A peer-reviewed paper proves Ivermectin, Mebendazole and Fenbendazole protocol treats/cures cancer", "assessment": "FALSE", "confidence": 0.95, "explanation": "No peer-reviewed paper proves these drugs treat or cure cancer in humans.

Assessment summary

  • The statement claims a peer-reviewed paper 'proves' a three-drug protocol cures cancer, which is not supported by available evidence.
  • High-quality clinical trials showing safety and efficacy in humans for ivermectin, mebendazole, or fenbendazole as a cancer cure do not exist, and major oncology bodies warn against their use outside trials asco.org cancer.org pmc.ncbi.nlm.nih.gov.

Claims reviewed

A peer-reviewed paper proves Ivermectin, Mebendazole and Fenbendazole protocol treats/cures cancer.

Incorrect
No peer-reviewed clinical trial demonstrates that a protocol of these three drugs cures cancer in humans; existing evidence is limited to preclinical studies, small case reports/series, and early-phase or exploratory trials for mebendazole only asco.org cancer.org pmc.ncbi.nlm.nih.gov nature.com.

This claim may mislead readers without added context.

This is the future of cancer treatment.

Misleading
While drug-repurposing research is active, expert reviews and oncology societies state evidence is insufficient to call these agents the future standard of care; more rigorous randomized trials would be required cancer.org fullfact.org.

This claim may mislead readers without added context.

Check your own claim

Paste any statement, headline, or AI answer. Independent assessments check it and compare sources.

Share this result